Everyday is something new.
the whole not getting vaccinated thing isn't really moving in your favor though, Brah
I’ll wait it out a bit, what I’m doing is working obviously cause I don’t play around when it comes to this thing. I’m not around a bunch of people and don’t plan to be either. I find it annoying they still can’t approve this fully vaccine though. Emergency use is not good enough IMO.
you sound like a smart cat hopefully you make the decision to get vaccinated sooner rather than later. Delta is way more infectious, and trust me that you don't want to catch this, my second dose gave me mild symptoms and they kicked my ass for two days

According to the Massachusetts Department of Public Health, 24 residents and nine staff members at the Maplewood at Mayflower Place nursing home have tested positive for COVID since July 10, The Boston Globe reported. The outbreak grew quickly: just last week, on July 16, the Cape Cod Times reported that over 10 people had tested positive for the virus.
Most of the residents that tested positive are vaccinated, and are asymptomatic or experiencing only mild symptoms, the Globe reported. COVID-positive residents were offered monoclonal antibody therapeutics, and positive staff are “stable,” according to the DPH.
“Our COVID-19 Task Force and our community leaders are working in close collaboration with them to monitor the positive cases of COVID-19 at Mayflower Place Nursing & Rehabilitation Center,” Kim Bragoli, director of marketing for Maplewood Senior Living, told the Globe in a statement. “We are pleased to see that our vaccination efforts have clearly been effective as affected residents and staff are exhibiting no or very limited symptoms at this time.”
Health experts are pointing to the vaccine’s success in preventing serious illness and hospitalization, recalling the devastating outbreaks at senior living facilities early in the pandemic.
“It’s usually a very mild form of a disease or even asymptomatic, and that’s exactly what happened here at the nursing home… It’s extremely effective in keeping patients out of the hospital, preventing serious illness and death,” Dr. Michael Misialek, associate chair of Pathology at Newton Wellesley Hospital, told Boston 25 News. “This would definitely be a different story had they not been vaccinated or could’ve played out similar to the Soldier’s Home where we saw the tragedy there back at the beginning of the pandemic.”
Two doses of Pfizer, AstraZeneca shots effective against Delta variant: study
LONDON, July 21 (Reuters) - Two doses of Pfizer (PFE.N) or AstraZeneca's (AZN.L) COVID-19 vaccine are nearly as effective against the highly transmissible Delta coronavirus variant as they are against the previously dominant Alpha variant, a study published on Wednesday showed.
Officials say vaccines are highly effective against the Delta variant, now the dominant variant worldwide, though the study reiterated that one shot of the vaccines is not enough for high protection.
The study, published in the New England Journal of Medicine, confirms headline findings given by Public Health England in May about the efficacy of COVID-19 vaccines made by Pfizer-BioNTech and Oxford-AstraZeneca (AZN.L), based on real-world data.
Wednesday's study found that two doses of Pfizer's shot was 88% effective at preventing symptomatic disease from the Delta variant, compared to 93.7% against the Alpha variant, broadly the same as previously reported.
Two shots of AstraZeneca vaccine were 67% effective against the Delta variant, up from 60% originally reported, and 74.5% effective against the Alpha variant, compared to an original estimate of 66% effectiveness.
"Only modest differences in vaccine effectiveness were noted with the Delta variant as compared with the Alpha variant after the receipt of two vaccine doses," Public Health England researchers wrote in the study.
Data from Israel has estimated lower effectiveness of Pfizer's shot against symptomatic disease, although protection against severe disease remains high.
PHE had previously said that a first dose of either vaccine was around 33% effective against symptomatic disease from the Delta variant.
The full study published on Wednesday found that one dose of Pfizer's shot was 36% effective, and one dose of AstraZeneca's vaccine was around 30% effective.
"Our finding of reduced effectiveness after the first dose would support efforts to maximise vaccine uptake with two doses among vulnerable groups in the context of circulation of the Delta variant," the authors of the study said.
Reporting by Alistair Smout; editing by Barbara Lewis